Trials Sponsors Conditions Drugs Pricing

Conditions

Cerebral Amyloid Angiopathy Hypertensive Arteriopathy

Outcome Measures

Primary Outcomes (11)

Sex
Comparaison of both populations (HA/CAA), H/F
baseline
Hypertension
history of hypertension (Yes/No)
baseline
Age
Age at time of T2-weighted imaging,
baseline
Time
Time between initial MRI-based CAA/HA diagnosis and 3T T2-weighted imaging, axial or coronal views of T2 imaging,
baseline
MRI view
T2 performed using coronal or axial imaging (axial / coronal
baseline
hypercholesterolemia
history of hypercholesterolemia (Yes/No)
baseline

Study Arms (2)

CAA

Patients with cerebral amyloid angiopathy

HA

Patients with Hypertensive arteriopathy

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Patients with lobar intracerebral hemorrhage \[ICH\], subarachnoid hemorrhage or cortical superficial siderosis for CAA or basal ganglion ICH for HA

You may qualify if:

Patient registered in the CHU de Nîmes (France) stroke database with lobar intracerebral hemorrhage \[ICH\], subarachnoid hemorrhage or cortical superficial siderosis for CAA or basal ganglion ICH for HA

Sponsors & Collaborators

Centre Hospitalier Universitaire de Nīmes
Otherlead

Study Sites (1)

CHU de Nîmes

Nîmes, Occitanie, 3029, France

MeSH Terms

Conditions

Cerebral Amyloid Angiopathy

Condition Hierarchy (Ancestors)

Cerebral Arterial DiseasesIntracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesAmyloidosisProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

Anissa MEGZARI
Centre Hospitalier Universitaire de Nīmes
STUDY DIRECTOR

Enrollment

72 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 10, 2025

First Posted

March 21, 2025

Study Start

April 1, 2025

Actual (reported)

Dilated Perivascular Spaces in the Dentate Nucleus on MRI in Patients With Hypertensive Angiopathy or Cerebral Amyloid Angiopathy

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (11)

Study Arms (2)

CAA

HA

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (11)

Study Arms (2)

CAA

HA

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations